Reducing agents inhibit rhinovirus‐induced up‐regulation of the rhinovirus receptor intercellular adhesion molecule‐1 (ICAM‐1) in respiratory epithelial cells

Abstract
SPECIFIC AIMSVirus infections (mostly rhinoviruses) are the major cause of exacerbations of airway disease. Intercellular adhesion molecule-1 (ICAM-1) is a cell surface glycoprotein involved in leukocyte trafficking and recruitment to sites of inflammation; it is also the cellular receptor for 90% of rhinovirus serotypes. Its expression in bronchial epithelium is increased by rhinovirus infection both in vivo and in vitro, making it a pivotal mediator of virus-induced inflammation in the respiratory tract. To investigate a potential role for antioxidants in reducing virus-induced inflammation, we investigated whether reducing agents inhibit in a dose-dependent manner rhinovirus-induced ICAM-1 up-regulation and mRNA induction in primary bronchial or A549 respiratory epithelial cells. We investigated whether reducing agents inhibit rhinovirus-induced ICAM-1 promoter and NF-κB activation. Furthermore, we analyzed whether rhinovirus infection increases oxidant production within airway epithelial cells. These ...
Funding Information
  • Deutsche Forschungsgemeinschaft (405/5 (KD))